| 1 | CRISPR/Cas13a‐Powered Electrochemical Microfluidic Biosensor for Nucleic Acid Amplification‐Free miRNA Diagnostics | Advanced Materials | 2019 | 342 |
| 2 | Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes | BJU International | 2014 | 323 |
| 3 | Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n−3 polyunsaturated fatty acids | Diabetologia | 2006 | 278 |
| 4 | Mutational spectrum in a worldwide study of 29,700 families withBRCA1orBRCA2mutations | Human Mutation | 2018 | 278 |
| 5 | Green tea extract and (−)‐epigallocatechin‐3‐gallate, the major tea catechin, exert oxidant but lack antioxidant activities | FASEB Journal | 2005 | 277 |
| 6 | Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients | Journal of Thrombosis and Haemostasis | 2018 | 272 |
| 7 | Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes | Cancer Research | 2004 | 218 |
| 8 | The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo | Proceedings of the National Academy of Sciences of the United States of America | 2008 | 144 |
| 9 | Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo | Cancer Research | 2004 | 135 |
| 10 | Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer | British Journal of Haematology | 2019 | 120 |
| 11 | A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma | British Journal of Haematology | 2013 | 119 |
| 12 | Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes | Allergy: European Journal of Allergy and Clinical Immunology | 2023 | 117 |
| 13 | Intrapleural administration of OK432 in cancer patients: Activation of nk cells and reduction of suppressor cells | International Journal of Cancer | 1983 | 110 |
| 14 | The KITD816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease | Allergy: European Journal of Allergy and Clinical Immunology | 2014 | 98 |
| 15 | JAK‐STAT core cancer pathway: An integrative cancer interactome analysis | Journal of Cellular and Molecular Medicine | 2022 | 88 |
| 16 | Particle therapy in Europe | Molecular Oncology | 2020 | 85 |
| 17 | Diffuse glioneuronal tumour with oligodendroglioma‐like features and nuclear clusters (DGONC) – a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14 | Neuropathology and Applied Neurobiology | 2020 | 73 |
| 18 | Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality | Journal of Thrombosis and Haemostasis | 2015 | 70 |
| 19 | Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification | Allergy: European Journal of Allergy and Clinical Immunology | 2020 | 68 |
| 20 | Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of theOVCADConsortium | Cancer Science | 2012 | 67 |
| 21 | Microparticle‐associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features | European Journal of Clinical Investigation | 2013 | 62 |
| 22 | Prognostic factors in patients with vulvar cancer: the VULCAN study | International Journal of Gynecological Cancer | 2020 | 62 |
| 23 | Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment | Journal of Thrombosis and Haemostasis | 2016 | 60 |
| 24 | DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia | European Journal of Clinical Investigation | 2014 | 59 |
| 25 | Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism | Journal of Thrombosis and Haemostasis | 2018 | 59 |
| 26 | Apremilast in psoriasis – a prospective real‐world study | Journal of the European Academy of Dermatology and Venereology | 2018 | 58 |
| 27 | Prognostic impact of genetic alterations and methylation classes in meningioma | Brain Pathology | 2022 | 57 |
| 28 | Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth‐inhibitory and VEGF‐suppressive effects of rapamycin in leukemic cells | FASEB Journal | 2005 | 56 |
| 29 | Magnetic field effects on particle beams and their implications for dose calculation in MR‐guided particle therapy | Medical Physics | 2017 | 56 |
| 30 | Prevalence of pain and its association with symptoms of post‐traumatic stress disorder, depression, anxiety and distress in 846 cancer patients: A cross sectional study | Psycho-Oncology | 2021 | 55 |
| 31 | BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils | Allergy: European Journal of Allergy and Clinical Immunology | 2017 | 54 |
| 32 | Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis | Genes Chromosomes and Cancer | 2018 | 54 |
| 33 | Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma | | 2020 | 54 |
| 34 | Diffusion‐weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy | NMR in Biomedicine | 2016 | 53 |
| 35 | Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review | Journal of Thrombosis and Haemostasis | 2022 | 53 |
| 36 | The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study | Research and Practice in Thrombosis and Haemostasis | 2019 | 52 |
| 37 | Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group | HemaSphere | 2020 | 52 |
| 38 | Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non–small cell lung cancer brain metastases | Cancer | 2020 | 49 |
| 39 | Massive release of the histamine‐degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients | Allergy: European Journal of Allergy and Clinical Immunology | 2019 | 48 |
| 40 | The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial | BJOG: an International Journal of Obstetrics and Gynaecology | 2005 | 47 |
| 41 | Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer | Cancer Science | 2014 | 47 |
| 42 | Non‐anaplastic peripheral T‐cell lymphoma in children and adolescents – a retrospective analysis of the NHL‐BFM study group | British Journal of Haematology | 2015 | 47 |
| 43 | Stressors alter intercellular communication and exosome profile of nasopharyngeal carcinoma cells | Journal of Oral Pathology and Medicine | 2017 | 47 |
| 44 | Rare non‐Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric‐type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T‐cell lymphoma | Pediatric Blood and Cancer | 2020 | 44 |
| 45 | Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues | Cytometry Part B - Clinical Cytometry | 2023 | 43 |
| 46 | Treatment outcome of CRLF2‐rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP‐BFM and UK NCRI‐CCLG study groups | British Journal of Haematology | 2012 | 40 |
| 47 | Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients | Clinical and Experimental Immunology | 2014 | 40 |
| 48 | Clinical activity of everolimus in relapsed/refractory marginal zone B‐cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group | British Journal of Haematology | 2014 | 40 |
| 49 | Screening for post‐traumatic stress disorders in 1017 cancer patients and correlation with anxiety, depression, and distress | Psycho-Oncology | 2019 | 40 |
| 50 | Technical Note: Dose prediction for radiation therapy using feature‐based losses and One Cycle Learning | Medical Physics | 2021 | 40 |
